Film Life, Inc. – Trademark Portfolio

Entity Type: 03

Film Life, Inc. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 14 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ABFF and BECAUSE HOLLYWOODN'T. The owner is based in New York, NY.

Suite 500

116 West 23rd Street

New York, NY 10011

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Film Life, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (14 filings)

Education; providing of training; entertainment; sporting and cultural activities

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Film Life, Inc. have?

Film Life, Inc. has 16 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned, 8 cancelled.

What trademark classes does Film Life, Inc. file in?

Film Life, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Film Life, Inc.'s most well-known trademarks?

Film Life, Inc.'s registered trademark portfolio includes well-known marks such as ABFF and BECAUSE HOLLYWOODN'T. These are among 3 currently registered trademarks in the portfolio.

What is Film Life, Inc.'s trademark registration success rate?

Film Life, Inc. has a 19% trademark registration rate, with 3 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.